QUELICIN is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Succinylcholine Chloride.
Product ID | 0409-6629_26d36f80-bc3b-48b4-a715-38a2759698cf |
NDC | 0409-6629 |
Product Type | Human Prescription Drug |
Proprietary Name | QUELICIN |
Generic Name | Succinylcholine Chloride |
Dosage Form | Injection, Solution |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
Marketing Start Date | 2005-04-30 |
Marketing Category | NDA / NDA |
Application Number | NDA008845 |
Labeler Name | Hospira, Inc. |
Substance Name | SUCCINYLCHOLINE CHLORIDE |
Active Ingredient Strength | 20 mg/mL |
Pharm Classes | Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2005-04-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA008845 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2005-04-30 |
Marketing Category | NDA |
Application Number | NDA008845 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2010-10-11 |
Marketing End Date | 2014-06-05 |
Marketing Category | NDA |
Application Number | NDA008845 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-10-11 |
Marketing Category | NDA |
Application Number | NDA008845 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2014-03-31 |
Marketing Category | NDA |
Application Number | NDA008845 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-05-08 |
Ingredient | Strength |
---|---|
SUCCINYLCHOLINE CHLORIDE | 20 mg/mL |
SPL SET ID: | c06156ae-b889-4250-bc85-1435b2635829 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0409-6629 | QUELICIN | Succinylcholine Chloride |
71872-7026 | Quelicin | Quelicin |
71872-7146 | Quelicin | Quelicin |
0781-3009 | Anectine | Succinylcholine Chloride |
0781-3411 | Anectine | Succinylcholine Chloride |
0781-9053 | Anectine | Succinylcholine Chloride |
0143-9338 | Succinylcholine Chloride | Succinylcholine Chloride |
0404-9960 | Succinylcholine Chloride | Succinylcholine Chloride |
0404-9983 | SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride |
0548-9801 | Succinylcholine Chloride | Succinylcholine Chloride |
0641-6234 | Succinylcholine Chloride | Succinylcholine Chloride |
14445-407 | Succinylcholine Chloride | Succinylcholine Chloride |
14789-104 | Succinylcholine Chloride | Succinylcholine Chloride |
16729-493 | Succinylcholine Chloride | Succinylcholine Chloride |
25021-677 | Succinylcholine Chloride | Succinylcholine Chloride |
31722-981 | Succinylcholine Chloride | Succinylcholine Chloride |
42571-371 | Succinylcholine Chloride | Succinylcholine Chloride |
49396-0152 | Succinylcholine Chloride | Succinylcholine Chloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
QUELICIN 77663899 3663637 Live/Registered |
Hospira, Inc. 2009-02-05 |
QUELICIN 71648976 0587354 Dead/Expired |
ABBOTT LABORATORIES 1953-06-18 |